{{Rsnum
|rsid=2631372
|Gene=SLC22A5
|Chromosome=5
|position=132367886
|Orientation=plus
|GMAF=0.2856
|Gene_s=MIR4750
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 53.2 | 39.6 | 7.2
| HCB | 42.2 | 51.1 | 6.7
| JPT | 32.7 | 53.6 | 13.6
| YRI | 70.5 | 27.4 | 2.1
| ASW | 69.1 | 27.3 | 3.6
| CHB | 42.2 | 51.1 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 17.5 | 47.4 | 35.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 53.9 | 36.2 | 9.9
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{Report GE
|PubMed=17684544
|Source=pubmed
|AffyProbeset=SNP_A-1983493
|AffyOrientation=reverse
|AlleleA=C
|AlleleB=G
|onGW5=1
|rsid=2631372
|ancestral=C
|RiskPopulation=EU(German)
|RiskAllele=C
|CaseFreq=0.72
|ControlFreq=0.69
|OddsRatioHet=
|OddsRatioHom=
|OddsRatioAll=1.28
|Disease=Crohn's disease
|DiseaseSymbol=CD
|OA=1
}}

rs2631372 increases susceptibility to Crohn's disease 1.28 times for carriers of the C allele {{PMID|17684544|OA=1
}}

{{PMID Auto
|PMID=21695374
|Title=Haplotype in the IBD5 region is associated with refractory Crohn's disease in Slovenian patients and modulates expression of the SLC22A5 gene
}}

{{PMID Auto
|PMID=23127916
|Title=Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | HumanOmni1Quad}}
{{on chip | NatGeo2}}